• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

7,427
3,692
3,577
2,969
2,901

COUNTRY

2,480
911
286
273
238

CATEGORIES

  • 931
  • 179
    • 43
    • 264
    • 51
  • 193
  • 829
    • 50
  • 509
  • 226
  • 242
  • 60
  • 66
  • 875
  • 1,525
  • 742
  • 20
  • 501
  • 1,434
  • 2,412
    • 85
    • 124
    • 66
    • 65
    • 37
    • 37
    • 12
    • 12
    • 11
    • 18
  • 23
  • 270
  • 30
  • 2,699
SHOW ALL…

PRICE

2,814
8,168
17,367
30,620

PUBLISHED

321
3,879
12,643
30,620

PRODUCT TYPE

27,666
1,095
1,026
506
163
58
25
21
19
16
6
3
1

Pharmaceuticals

(30,620 Products)

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE
Drug Delivery in Cancer - Technologies, Markets and Companies Drug Delivery in Cancer - Technologies, Markets and Companies - Product Thumbnail Image

Drug Delivery in Cancer - Technologies, Markets and Companies

Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable research is in progress for drug discovery...

June 2015
FROM
Therapeutic Drug Monitoring - Technologies, Markets, and Companies Therapeutic Drug Monitoring - Technologies, Markets, and Companies - Product Thumbnail Image

Therapeutic Drug Monitoring - Technologies, Markets, and Companies

This report deals with therapeutic drug monitoring, a multi-disciplinary clinical specialty, aimed at improving patient care by monitoring drug levels in the blood to individually adjust the dose of...

June 2015
FROM
Cardiovascular Drug Delivery - Technologies, Markets and Companies Cardiovascular Drug Delivery - Technologies, Markets and Companies - Product Thumbnail Image

Cardiovascular Drug Delivery - Technologies, Markets and Companies

Drug delivery to the cardiovascular system is different from delivery to other systems because of the anatomy and physiology of the vascular system; it supplies blood and nutrients to all organs of...

June 2015
FROM
Alzheimer Disease - New Drugs, Markets and Companies Alzheimer Disease - New Drugs, Markets and Companies - Product Thumbnail Image

Alzheimer Disease - New Drugs, Markets and Companies

Alzheimer's disease remains a challenge in management. With nearly 8 million sufferers from this condition in the seven major markets of the world and anticipated increases in the future. Considerable...

June 2015
FROM
Personalized Medicine - Scientific and Commercial Aspects Personalized Medicine - Scientific and Commercial Aspects - Product Thumbnail Image

Personalized Medicine - Scientific and Commercial Aspects

The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her...

June 2015
FROM
Pain Therapeutics - Drugs, Markets and Companies Pain Therapeutics - Drugs, Markets and Companies - Product Thumbnail Image

Pain Therapeutics - Drugs, Markets and Companies

This report describes the latest concepts of pathomechanisms of pain as a basis for management and development of new pharmacotherapies for pain. Major segments of the pain market are arthritis, neuropathic...

June 2015
FROM
Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies - Product Thumbnail Image

Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies

The delivery of drugs to central nervous system (CNS) is a challenge in the treatment of neurological disorders. Drugs may be administered directly into the CNS or administered systematically (e.g.,...

June 2015
FROM
The Future of Pharmaceutical Outsourcing The Future of Pharmaceutical Outsourcing - Product Thumbnail Image

The Future of Pharmaceutical Outsourcing

As they are in a desperate need to develop better drugs with high success rates and low cost, drug companies have been increasingly utilizing external resources to increase their efficiency and enhance...

June 2015
FROM
Singapore Pharmaceuticals and Healthcare Report Q3 2015 Singapore Pharmaceuticals and Healthcare Report Q3 2015 - Product Thumbnail Image

Singapore Pharmaceuticals and Healthcare Report Q3 2015

Singapore's healthcare system will continue to evolve, led by changes from the government. This is reflected in the distinct shift in policy that will see the authorities raising its contribution to...

May 2015
Taiwan Pharmaceuticals and Healthcare Report Q3 2015 Taiwan Pharmaceuticals and Healthcare Report Q3 2015 - Product Thumbnail Image

Taiwan Pharmaceuticals and Healthcare Report Q3 2015

The Taiwanese pharmaceutical market will continue to be highly attractive for multinational drugmakers. As the seventh largest market in the Asia Pacific, the country's commercial opportunities are...

May 2015
Bulgaria Pharmaceuticals and Healthcare Report Q3 2015 Bulgaria Pharmaceuticals and Healthcare Report Q3 2015 - Product Thumbnail Image

Bulgaria Pharmaceuticals and Healthcare Report Q3 2015

Pharmaceutical manufacturers will face increased pricing pressures from the National Health Insurance Fund (NHIF) as we expect a wave of cost-containment measures to be adopted. The NHIF will leverage...

May 2015
Latvia Pharmaceuticals and Healthcare Report Q3 2015 Latvia Pharmaceuticals and Healthcare Report Q3 2015 - Product Thumbnail Image

Latvia Pharmaceuticals and Healthcare Report Q3 2015

Latvia's pharmaceutical market offers stable growth, at least in local currency terms, although the country will continue to present a modest opportunity to larger multinational companies on account...

May 2015
Romania Pharmaceuticals and Healthcare Report Q3 2015 Romania Pharmaceuticals and Healthcare Report Q3 2015 - Product Thumbnail Image

Romania Pharmaceuticals and Healthcare Report Q3 2015

We expect growth in pharmaceutical sales in 2015 to be primarily driven by Romania's improving macroeconomic outlook and a positive consumer story. We note that local regulatory factors such as revenue...

May 2015
Lebanon Pharmaceuticals and Healthcare Report Q3 2015 Lebanon Pharmaceuticals and Healthcare Report Q3 2015 - Product Thumbnail Image

Lebanon Pharmaceuticals and Healthcare Report Q3 2015

East region. In addition to this, the government's commitment to achieving universal access to healthcare will drive growth in the pharmaceutical market. Generic drug makers will see strong growth following...

May 2015
Uganda Pharmaceuticals and Healthcare Report Q3 2015 Uganda Pharmaceuticals and Healthcare Report Q3 2015 - Product Thumbnail Image

Uganda Pharmaceuticals and Healthcare Report Q3 2015

Recently Civil society organisations in Uganda have urged the country's legislators to reject the proposed budget reductions by 4% for the health sector for FY15/16. The reduction would severely affect...

May 2015
Estonia Pharmaceuticals and Healthcare Report Q3 2015 Estonia Pharmaceuticals and Healthcare Report Q3 2015 - Product Thumbnail Image

Estonia Pharmaceuticals and Healthcare Report Q3 2015

Estonian pharmaceutical sales posted larger than expected growth in 2014, and we have revised our ten year forecast upwards to reflect this new data. We expect pharmaceutical sales growth to decelerate...

May 2015
Cough, Cold and Allergy (Hay Fever) Remedies in Macedonia Cough, Cold and Allergy (Hay Fever) Remedies in Macedonia - Product Thumbnail Image

Cough, Cold and Allergy (Hay Fever) Remedies in Macedonia

Cough, cold and allergy (hay fever) remedies in Macedonia achieved 3% growth in 2014 to reach sales of MKD317 million thanks to an unusually cold, windy and rainy spring and summer and a very early...

May 2015
FROM
Analgesics in Macedonia Analgesics in Macedonia - Product Thumbnail Image

Analgesics in Macedonia

Analgesics achieved 2% growth in 2014 to reach sales of MKD703 million as the trend of self-medicating continued, despite a minor decline in unit price during the year. The Analgesics in Macedonia...

May 2015
FROM
Digestive Remedies in Macedonia Digestive Remedies in Macedonia - Product Thumbnail Image

Digestive Remedies in Macedonia

Digestive remedies achieved 3% growth in 2014 to reach sales of MKD114 million thanks to the growing trend towards self-medication and increased availability of standard and herbal/traditional OTC digestive...

May 2015
FROM
Cameroon Pharmaceuticals and Healthcare Report Q3 2015 Cameroon Pharmaceuticals and Healthcare Report Q3 2015 - Product Thumbnail Image

Cameroon Pharmaceuticals and Healthcare Report Q3 2015

Headline Expenditure Projections - Pharmaceuticals: XAF170.33bn (USD348mn) in 2014 to XAF187.60bn (USD315mn) in 2015; +10.1% in local currency terms and -9.6% in US dollar terms. Forecast revised downwards...

May 2015
Loading Indicator

Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S